Jon CongletonPresident and Chief Executive Officer
Remote company profile
Mineralys Therapeutics, Inc. remote work and careers
Public, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for hypertension
BiotechnologyHealthcareScience
Company overview
About Mineralys Therapeutics, Inc.
At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.
Purpose
Mission and direction
Mineralys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for hypertension and related cardio-renal conditions. The company is focused on moving beyond one-size-fits-all treatment by advancing a personalized approach to managing diseases driven by dysregulated aldosterone, with the goal of improving outcomes for patients with hypertension, chronic kidney disease, obstructive sleep apnea, and related disorders.
How they work
Company values
- Innovation
- Patient-focused
- Precision medicine
- Integrity
- Collaboration
- Excellence
Leadership